Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5466)
All Articles published online
|
Dec 14, 2010 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rey JW, Noetel A, Hardt A, Canbay A, Alakus H, Hausen AZ, Dienes HP, Drebber U, Odenthal M. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases. World J Gastroenterol 2010; 16(46): 5830-5837 [PMID: 21155004 DOI: 10.3748/wjg.v16.i46.5830] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i46/5830.htm |
| Number | Citing Articles |
| 1 |
Samer Gawrieh, Miranda C. Marion, Richard Komorowski, James Wallace, Michael Charlton, Ahmed Kissebah, Carl D. Langefeld, Michael Olivier. Genetic Variation in the Peroxisome Proliferator Activated Receptor-Gamma Gene Is Associated with Histologically Advanced NAFLD. Digestive Diseases and Sciences 2012; 57(4): 952 doi: 10.1007/s10620-011-1994-2
|
| 2 |
Gene P. Ables. Update on Ppar and Nonalcoholic Fatty Liver Disease. PPAR Research 2012; 2012: 1 doi: 10.1155/2012/912351
|
| 3 |
Kayleigh L Wood, Michael H Miller, John F Dillon. Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver disease. BMJ Open Gastroenterology 2015; 2(1): e000019 doi: 10.1136/bmjgast-2014-000019
|
| 4 |
Marion Peyrou, Pierluigi Ramadori, Lucie Bourgoin, Michelangelo Foti. PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs. PPAR Research 2012; 2012: 1 doi: 10.1155/2012/757803
|
| 5 |
Yeting Hou, Bingzhong Su, Ping Chen, Haijing Niu, Sheng Zhao, Ruijun Wang, Wei Shen. Association of SIRT1 gene polymorphism and its expression for the risk of alcoholic fatty liver disease in the Han population. Hepatology International 2018; 12(1): 56 doi: 10.1007/s12072-017-9836-8
|
| 6 |
Paola Dongiovanni, Luca Valenti. Peroxisome Proliferator-Activated Receptor Genetic Polymorphisms and Nonalcoholic Fatty Liver Disease: Any Role in Disease Susceptibility?. PPAR Research 2013; 2013: 1 doi: 10.1155/2013/452061
|
| 7 |
Nan Qi, Chen Liu, Haoran Yang, Wanrong Shi, Shenyi Wang, Yan Zhou, Cai Wei, Fang Gu, Yide Qin. Therapeutic hexapeptide (PGPIPN) prevents and cures alcoholic fatty liver disease by affecting the expressions of genes related with lipid metabolism and oxidative stress. Oncotarget 2017; 8(50): 88079 doi: 10.18632/oncotarget.21404
|
| 8 |
Jun Wang, Xufeng Guo, Pengbo Wu, Jia Song, Chuncui Ye, Shijie Yu, Jixiang Zhang, Weiguo Dong. Association between the Pro12Ala polymorphism of PPAR-γ gene and the non-alcoholic fatty liver disease: A meta-analysis. Gene 2013; 528(2): 328 doi: 10.1016/j.gene.2013.07.014
|
| 9 |
Quentin M. Anstee, Devanshi Seth, Christopher P. Day. Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease. Gastroenterology 2016; 150(8): 1728 doi: 10.1053/j.gastro.2016.01.037
|
| 10 |
Fabio Salvatore Macaluso, Marcello Maida, Salvatore Petta. Genetic background in nonalcoholic fatty liver disease: A comprehensive review. World Journal of Gastroenterology 2015; 21(39): 11088-11111 doi: 10.3748/wjg.v21.i39.11088
|
| 11 |
Karen D. Corbin, Manal F. Abdelmalek, Melanie D. Spencer, Kerry‐Ann Costa, Joseph A. Galanko, Wei Sha, Ayako Suzuki, Cynthia D. Guy, Diana M. Cardona, Alfonso Torquati, Anna Mae Diehl, Steven H. Zeisel. Genetic signatures in choline and 1‐carbon metabolism are associated with the severity of hepatic steatosis. The FASEB Journal 2013; 27(4): 1674 doi: 10.1096/fj.12-219097
|
| 12 |
Roberta Goncalves Marangoni, Benjamin D Korman, Yannick Allanore, Philippe Dieude, Loren L Armstrong, Margarita Rzhetskaya, Monique Hinchcliff, Mary Carns, Sofia Podlusky, Sanjiv J Shah, Barbara Ruiz, Eric Hachulla, Kiet Tiev, Jean-Luc Cracowski, John Varga, M Geoffrey Hayes. A candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) gene and systemic sclerosis. Arthritis Research & Therapy 2015; 17(1) doi: 10.1186/s13075-015-0641-2
|
| 13 |
Young Ho Lee, Sang-Cheol Bae, Gwan Gyu Song. Meta-Analysis of Associations Between the Peroxisome Proliferator-Activated Receptor-γ Pro12Ala Polymorphism and Susceptibility to Nonalcoholic Fatty Liver Disease, Rheumatoid Arthritis, and Psoriatic Arthritis. Genetic Testing and Molecular Biomarkers 2014; 18(5): 341 doi: 10.1089/gtmb.2013.0503
|
| 14 |
Omar Ramos-Lopez, Erika Martinez-Lopez, Sonia Roman, Nora A Fierro, Arturo Panduro. Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico. World Journal of Gastroenterology 2015; 21(41): 11552-11566 doi: 10.3748/wjg.v21.i41.11552
|
| 15 |
Rohini Mehta, Aybike Birerdinc, Zobair M. Younossi. Host Genetic Variants in Obesity-Related Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 2014; 18(1): 249 doi: 10.1016/j.cld.2013.09.017
|
| 16 |
Syeda Momna Ishtiaq, Muhammad Imran Arshad, Junaid Ali Khan. PPARγ signaling in hepatocarcinogenesis: Mechanistic insights for cellular reprogramming and therapeutic implications. Pharmacology & Therapeutics 2022; 240: 108298 doi: 10.1016/j.pharmthera.2022.108298
|
| 17 |
Rong Xie, Shaobo Tang, Yanna Yang. Associations of peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism with non-alcoholic fatty liver disease: A meta-analysis. Journal of Diabetes and its Complications 2022; 36(10): 108261 doi: 10.1016/j.jdiacomp.2022.108261
|
| 18 |
Fernanda Aparecida Domenici, Maria José Franco Brochado, Ana de Lourdes Candolo Martinelli, Sergio Zucoloto, Selma Freire de Carvalho da Cunha, Helio Vannucchi. Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: A study in Brazilian patients. Gene 2013; 529(2): 326 doi: 10.1016/j.gene.2013.06.091
|
| 19 |
Yinxia Su, Zhenhui Liu, Lei Yang, Yuanyuan Li, Sheng Jiang, Hua Yao, Guoli Du. PPARγ gene Pro12Ala variants reduce the risk of obese individuals to non-alcoholic fatty liver: A study in Uygur Chinese population residing in Northwestern China. Clinics and Research in Hepatology and Gastroenterology 2020; 44(6): 894 doi: 10.1016/j.clinre.2020.02.005
|
| 20 |
Leila Saremi, Shirin Lotfipanah, Masumeh Mohammadi, Hassan Hosseinzadeh, Mina Fathi-Kazerooni, Behrooz Johari, Zohreh Saltanatpour. The Pro12Ala polymorphism in the PPARγ2 gene is not associated with an increased risk of NAFLD in Iranian patients with type 2 diabetes mellitus. Cellular & Molecular Biology Letters 2019; 24(1) doi: 10.1186/s11658-019-0138-0
|
| 21 |
Roman Müllenbach, Susanne N. Weber, Frank Lammert. Nuclear Receptor Variants in Liver Disease. Journal of Lipids 2012; 2012: 1 doi: 10.1155/2012/934707
|
| 22 |
Hisamitsu Miyaaki, Kazuhiko Nakao. Significance of genetic polymorphisms in patients with nonalcoholic fatty liver disease. Clinical Journal of Gastroenterology 2017; 10(3): 201 doi: 10.1007/s12328-017-0732-5
|
| 23 |
Surya Prakash Bhatt, Priyanka Nigam, Anoop Misra, Randeep Guleria, Kalpana Luthra, Ravindra Mohan Pandey, M.A. Qadar Pasha. Association of peroxisome proliferator activated receptor-γ gene with non-alcoholic fatty liver disease in Asian Indians residing in north India. Gene 2013; 512(1): 143 doi: 10.1016/j.gene.2012.09.067
|
| 24 |
Ruben Hernaez. Genetics of non-alcoholic fatty liver disease and associated metabolic disorders. Avances en Diabetología 2011; 27(6): 186 doi: 10.1016/j.avdiab.2011.11.004
|
| 25 |
Amirhossein Sahebkar. Does PPARγ2 Gene Pro12Ala Polymorphism Affect Nonalcoholic Fatty Liver Disease Risk? Evidence from a Meta-Analysis. DNA and Cell Biology 2013; 32(4): 188 doi: 10.1089/dna.2012.1947
|
| 26 |
Syeda Momna Ishtiaq, Muhammad Imran Arshad, Junaid Ali Khan. Pparγ Signaling in Hepatocarcinogenesis: Mechanistic Insights for Cellular Reprogramming and Therapeutic Implications. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4192515
|
| 27 |
Ruben Hernaez. Genetic factors associated with the presence and progression of nonalcoholic fatty liver disease: A narrative review. Gastroenterología y Hepatología 2012; 35(1): 32 doi: 10.1016/j.gastrohep.2011.08.002
|
| 28 |
Chuang-Yu Cao, Yu-Yuan Li, Yong-Jian Zhou, Yu-Qiang Nie, Yu-Jui Yvonne Wan. The C-681G Polymorphism of the PPAR-γ Gene Is Associated with Susceptibility to Non-Alcoholic Fatty Liver Disease. The Tohoku Journal of Experimental Medicine 2012; 227(4): 253 doi: 10.1620/tjem.227.253
|